ViewRay, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRAY research report →
About the company
ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom.
- CEO
- Paul Ziegler Jr.,
- IPO
- 2015
- Employees
- 295
- HQ
- Oakwood, OH, US
Price Chart
- Market Cap
- $4.56M
- P/E
- -0.04
- P/S
- 0.04
- P/B
- 0.05
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
- Gross Margin
- 9.83%
- Op Margin
- -104.81%
- Net Margin
- -105.21%
- ROE
- -85.33%
- ROIC
- -60.29%
- Revenue
- $102.21M · 45.76%
- Net Income
- $-107,533,000 · -1.32%
- EPS
- $-0.60 · 7.69%
- Op Income
- $-107,127,000
- FCF YoY
- -50.21%
- 52W High
- $0.04
- 52W Low
- $0.02
- 50D MA
- $0.03
- 200D MA
- $0.03
- Beta
- 0.70
- Avg Volume
- 96.17M
Get TickerSpark's AI analysis on VRAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 15, 23 | Shah Sanket | other | 350,000 |
| Jul 21, 23 | Shah Sanket | sell | 30,364 |
| Jul 15, 23 | Podbelski Adam Andrew | other | 350,000 |
| Jul 17, 23 | Podbelski Adam Andrew | sell | 89,901 |
| Jul 15, 23 | Shah Sanket | other | 0 |
| Jul 15, 23 | Shah Sanket | other | 30,000 |
| Jul 15, 23 | Shah Sanket | other | 31,773 |
| Jul 15, 23 | Podbelski Adam Andrew | other | 0 |
| Jul 15, 23 | Podbelski Adam Andrew | other | 24,000 |
| Jul 15, 23 | Podbelski Adam Andrew | other | 70,327 |
Our VRAY coverage
Recent articles, reports, and earnings notes.
No research on VRAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRAY report →Similar companies
Peers in the same neighborhood.